Patient age, histologic features, and length of survival in patients with glioblastoma multiforme

作者: Peter C. Burger , Sylvan B. Green

DOI: 10.1002/1097-0142(19870501)59:9<1617::AID-CNCR2820590916>3.0.CO;2-X

关键词:

摘要: Histologic sections from 71 patients with glioblastoma multiforme were reviewed to identify histologic prognostic factors and explain the significantly shorter survival in older patients. Slides studied for 14 variables a group of 35 aged less 45 years 36 65 or more. The relation these length age was then investigated. results document marked cytologic heterogeneity reaffirm importance necrosis as factor. further suggest that whose glioblastomas contained microcysts, pseudopalisading, cells astrocytic differentiation, large areas better differentiated glioma, did than those lesions homogeneously composed small lesion had median nuclear size. study reaffirmed strong (P 0.0001) negative relationship between advancing duration postoperative survival. presence necrosis, smaller standard deviation size, extent vascular proliferation, absence well neoplastic fibrillary astrocytes, neoplasms related patient offered possible explanation at least part observed effect. However, remained significant when adjusted other variables, effect must rest largely on detected this morphologic study.

参考文章(22)
David P. Byar, Sylvan B. Green, Thomas A. Strike, Prognostic Factors for Malignant Glioma Springer US. pp. 379- 395 ,(1983) , 10.1007/978-1-4613-3858-1_14
Lucien Jules Rubinstein, Tumors of the central nervous system Armed Forces Institute of Pathology; sold by American Registry of Pathology. ,(1972)
J. Ransohoff, C. B. Wilson, M. D. Walker, S. B. Green, D. P. Byar, J. T. Robertson, J. Mealey, W. R. Shapiro, R. G. Selker, T. A. Strike, W. H. Brooks, K. R. Smith, P. Paoletti, U. Batzdorf, G. L. Odom, D. A. Pistenmaa, W. E. Hunt, E. Alexander, Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer treatment reports. ,vol. 67, pp. 121- 132 ,(1983)
J. Gregory Cairncross, The biology of Astrocytoma : Lessons learned from chronic myelogenous leukemia—hypothesis Journal of Neuro-oncology. ,vol. 5, pp. 99- 104 ,(1987) , 10.1007/BF02571297
Emmanuel Farber, The malignant phenotype as a late expression of the carcinogenic process Journal of Cellular Physiology. ,vol. 121, pp. 123- 125 ,(1984) , 10.1002/JCP.1041210415
J. S. Nelson, Y. Tsukada, D. Schoenfeld, K. Fulling, J. Lamarche, N. Peress, Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas Cancer. ,vol. 52, pp. 550- 554 ,(1983) , 10.1002/1097-0142(19830801)52:3<550::AID-CNCR2820520327>3.0.CO;2-C
K. Takeuchi, K. Hoshino, Statistical analysis of factors affecting survival after glioblastoma multiforme. Acta Neurochirurgica. ,vol. 37, pp. 57- 73 ,(1977) , 10.1007/BF01401926
W. M�ller, D. �fra, R. Schr�der, Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with astrocytomas. Acta Neurochirurgica. ,vol. 37, pp. 75- 91 ,(1977) , 10.1007/BF01401927